Interstitial Lung Disease Clinical Trials in New York, New York

12 recruitingNew York, New York

Showing 112 of 12 trials

Recruiting
Phase 3

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

Interstitial Lung DiseasesSystemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim400 enrolled158 locationsNCT06806592
Recruiting
Phase 3

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Interstitial Lung DiseasesFamilial Pulmonary FibrosisInterstitial Lung Abnormalities
Boehringer Ingelheim80 enrolled56 locationsNCT07201922
Recruiting

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Interstitial Lung DiseasePulmonary HypertensionPulmonary Hypertension Due to Lung Diseases and Hypoxia
United Therapeutics900 enrolled62 locationsNCT06388421
Recruiting
Phase 3

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Progressive Pulmonary FibrosisInterstitial Lung Disease
United Therapeutics698 enrolled152 locationsNCT05943535
Recruiting
Phase 2

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+4 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease
Duke University3,000 enrolled41 locationsNCT01915511
Recruiting

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Interstitial Lung DiseasePulmonary Hypertension
United Therapeutics300 enrolled42 locationsNCT05776225
Recruiting
Phase 2

Platform Clinical Study for Conquering Scleroderma

SclerodermaInterstitial Lung Disease Due to Systemic Disease
Scleroderma Research Foundation, Inc.400 enrolled34 locationsNCT06195072
Recruiting
Phase 2Phase 3

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

Scleroderma, SystemicSystemic Sclerosis Associated Interstitial Lung Disease
GlaxoSmithKline300 enrolled131 locationsNCT05878717
Recruiting

Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies

SmokingSmoking CessationChronic Obstructive Pulmonary Disease (COPD)+3 more
Weill Medical College of Cornell University2,000 enrolled1 locationNCT01776398
Recruiting
Phase 2

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Interstitial Lung Disease
aTyr Pharma, Inc.25 enrolled15 locationsNCT05892614
Recruiting

WTC Chest CT Imaging Archive

Lung CancerChronic Airway DiseaseInterstitial Lung Disease
Icahn School of Medicine at Mount Sinai2,122 enrolled1 locationNCT03295279